Skip to main content

Table 2 Neudesin concentration [ng/mL] obtained in serum, CSF, and Quotient value of patients with CNS tumors compared to non-tumoral individuals

From: Serum and cerebrospinal fluid Neudesin concentration and Neudesin Quotient as potential circulating biomarkers of a primary brain tumor

 

Total brain tumor

Astrocytic brain tumor

Meningeal tumor

Non-tumoral group

Serum

1.16 (0.94–1.68)#

1.24 (0.92–1.90)

1.07 (0.96–1.37)#

1.47 (1.39–1.99)

CSF

1.18 (0.80–2.17)

1.31 (0.93–2.17)#

0.66 (0.28–1.79)

0.98 (0.78–1.12)

Quotient

0.98 (0.47–1.33)

0.99 (0.78–1.33)#

0.62 (0.28–1.41)

0.56 (0.43–1.00)

  1. #statistically significant versus non-tumoral group (P < 0.05)
  2. Results are presented as median and interquartiles